| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.0007 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.004 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.39 | 0.004 |